499 related articles for article (PubMed ID: 16503857)
21. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
22. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
23. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
25. Postoperative radiation therapy for squamous cell carcinoma of the head and neck.
Mendenhall WM; Amdur RJ; Hinerman RW; Villaret DB; Siemann DW
Am J Otolaryngol; 2003; 24(1):41-50. PubMed ID: 12579482
[TBL] [Abstract][Full Text] [Related]
26. Advances in radiation therapy of head and neck cancer.
Popovtzer A; Eisbruch A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
28. [Current status of clinical trials on pre- and postoperative chemotherapy for head and neck cancer].
Inuyama Y; Fukuda S; Horiuchi M
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():338-47. PubMed ID: 7986113
[TBL] [Abstract][Full Text] [Related]
29. [Adjuvant treatment of head and neck cancers: advances and challenges].
Bernier J
Bull Cancer; 2007 Sep; 94(9):823-7. PubMed ID: 17878103
[TBL] [Abstract][Full Text] [Related]
30. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
Rosenthal DI; Blanco AI
Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
[TBL] [Abstract][Full Text] [Related]
32. Rationale for triage in the postoperative management of head and neck cancers.
Cooper JS; Bernier J
Oncology (Williston Park); 2005 Jul; 19(8):1011-7; discussion 1018, 1023-4, 1027. PubMed ID: 16131044
[TBL] [Abstract][Full Text] [Related]
33. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
34. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
36. Concurrent chemotherapy and radiotherapy for head and neck cancer.
Burri RJ; Lee NY
Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?
Lin CY; Lee LY; Huang SF; Kang CJ; Fan KH; Wang HM; Chen EY; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1373-81. PubMed ID: 18374224
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy with concomitant chemotherapy for head and neck cancer.
Vokes EE; Awan AM; Weichselbaum RR
Hematol Oncol Clin North Am; 1991 Aug; 5(4):753-67. PubMed ID: 1890065
[TBL] [Abstract][Full Text] [Related]
39. Future chemotherapy and radiotherapy options in head and neck cancer.
Merlano M; Mattiot VP
Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
